Patients Using Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound Seek Legal Compensation for Vision Loss

(Posted by Tom Lamb at Drug Injury Watch)

In December 2025, GLP-1 lawsuits involving NAION filed in federal court were consolidated by the U.S. Judicial Panel on Multidistrict Litigation (JPML). This ruling keeps drug injury lawsuits for the NAION eye side effect associated with the GLP-1 agonists class of drugs — such as Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound — separate from other injuries, like gastroparesis, that have been reported in recent years.

As of August 2026, MDL-3163 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation had 200 GLP-1 lawsuits involving NAION pending before U.S. District Judge Karen S. Marston, in the Eastern District of Pennsylvania. See: MDL Statistics Report – Distribution of Pending MDL Dockets by District, Report Date: 8/3/2026.

More possible GLP-1 lawsuits involving NAION are being investigated, and that number of 200 federal court cases will continue to increase in the coming months.

Further, there are additional GLP-1 lawsuits involving NAION filed in various state courts around the country on behalf of patients using Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound who are seeking legal compensation for their vision loss due to nonarteritic anterior ischemic optic neuropathy (NAION).

Here is a list of past relevant Drug Injury Watch articles just from this year, 2026:

Ozempic Eye Problems Side Effect Warnings Not In US Drug Label

Semaglutide-associated Vision Loss Due to NAION – New Medical Report, May 2026

Ozempic And Other GLP-1RA Use Associated With NAION Eye Side Effect

Wegovy and Ozempic Vision Loss: Wegovy Rate 5x Higher vs. Ozempic, Men 3x More Often vs. Women

While Rybelsus Pills Are Being Replaced With Pills Called Ozempic, Semaglutide NAION Risk Remains

Risk of NAION With Semaglutide Medicines is 2 Times Higher Than SGLT2i Diabetes Drugs

NAION Eye Side Effect for Ozempic and Mounjaro: Drug Injury Lawsuits Update January 2026

Patients using Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound who have been diagnosed with NAION and suffered vision loss can submit an online Case Evaluation Form to have their case reviewed by drug injury lawyer Tom Lamb:

Ozempic / Wegovy / Rybelsus Vision Loss Case Evaluation Form

Zepbound / Mounjaro Eye Side Effect NAION Case Evaluation Form

Or, if you prefer, call 910-256-2971 to speak directly with attorney Tom Lamb about a possible Ozempic, Wegovy, Rybelsus, Mounjaro, or Zepbound drug injury lawsuit seeking legal compensation for this NAION eye side effect.

DrugInjuryLaw.com: Medical & Legal Information About Drug Side Effects

Drug Injury Case Evaluation – Free. Confidential. No Obligation.